3. Albayrak CU, Çal flkan Ü. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36:

Size: px
Start display at page:

Download "3. Albayrak CU, Çal flkan Ü. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 1447-1449."

Transcription

1 ANKAFERD B L MSEL ÇALIfiMALAR 1. Göker H, Haznedaro lu IC, Erçetin S, Kirazl S, Akman U, Öztürk Y, F rat HC. Haemostatic Actions of Folkloric Medicinal Plant Extract Ankaferd Blood Stopper. J Int Med Research 2008; 36: Haznedaro lu BZ, Haznedaro lu IC, Walker SL, Bilgili H, Göker H, Koflar A, Aktafl A, Captug Ö, Kurt M, Özdemir O, Kirazl S, F rat HC. Ultrastructural and Morphological Analyses of the In vitro and In vivo Hemostatic Effects of Ankaferd Blood Stopper. Clinical&Applied Thrombosis/Hemostasis doi: / Albayrak CU, Çal flkan Ü. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: Ayd n S. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2009;37: Göker H, Haznedaro lu IC, Erçetin S, Kirazl fi, Akman Ü, Öztürk Y, F rat CH. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. Abstract no ASH Annual Meeting.Atlanta, Georgia. 6. Demiralp DÖ, Akar N, Haznedaro lu IC, Gümüfltekin Ç, Göker H. Kanama Durdurucu Ankafer ve Etki Mekanizmas n n Proteomik Analizi. Abstrakt. 10. Ulusal ç Hastal klar Kongresi. 2008, Antalya. 7. Y lmaz E, Güleç fi, Haznedaro lu I, Akar N, Hemostatik ajan Ankafer'in nsan Umblikal ven Endotelinde transkripsiyon faktörleri ve eritrosit protein profili üzerine etkisi. Bildiri no: 83. Poster no: P035. XXXIV. Ulusal Hematoloji Kongresi. 8. Karab y k A, Y lmaz E, Güleç fi, Akar N, Huvec Hücre Modelinde Lipopolisakkarit (LPS) Muamelesinden Sonra Ankaferd in EPCR ve PAI-1 Ekspresyonlar na Etkisinin ncelenmesi, XXXV. Ulusal Hematoloji Kongresi 2009, Antalya. 9. Eyi E. G. Y., Yapar E. A. Ar N., Mollamahmuto lu L., Haznedaro lu. C., Ankaferd Blood Stopper in S çan Abdominal Kanama Modeline In Vivo Hemostatik Etkisi, J Gynecol-Obstet Neonatal 2008; 3: Huri E, Akgül T, Yücel O, Astarc M, Üstün H, Germiyano lu C, The Second Step in Vitro of Ankaferd Bloodstopper: Comparison With the Other Hemostatic Agents, Glubran 2, Floseal and Celox, EAU 5.th South Eastern European Meeting (Seem) / European Urology Supplements 8 (2009) TEMEL B L M ARAfiTIRMALARI 1. Haznedaro lu IC, Molecular Basis of the Pleotropic Effects of Ankaferd Blood Stopper, IUBMB Life Supplement Volume 61 Number Y lmaz E, Güleç fi, Haznedaro lu, Akar N, Hemostatik Ajan Ankaferd in nsan Umbilical Ven Endotelinde Transkripsiyon Faktörleri ve Eritrosit Protein Profili Üzerine Etkisi, XXXIV. Ulusal Hemotoloji Kongresi 2008 zmir. 3. Akar N, Demiralp DO, Haznedaro lu IC, Göker H, Functional Proteomics of Ankaferd Blood Stopper, Blood (ASH Annual Meeting Abstracts) : Abstracts Huri E, Akgül T, Astarc M, Üstün H, Germiyano lu C, The Effect of a Novel Hemostatic Agent, Ankaferd Bloodstopper (ABS), on Renal Tubular Apoptosis in Rat Partial Nephrectomy Model, EAU 5.th South Eastern European Meeting (Seem) / European Urology Supplements 8 (2009) Demiralp DÖ, Akar N, Haznedaro lu IC, Gümüfltekin Ç, Göker H, Ankaferd in Kanama Durdurucu Etkisinin Proteomik Analizi, XXXIV. Ulusal Hematoloji Kongresi 2008 zmir. 6. K l ç E, Çetinkaya DU, Haznedaro lu C, Turgut M, Aksu S, Kirazl fi, Goker H, Ankaferd Blood Stopper n (ABS), n Vitro Ortamda Mezenkimal Kök Hücrelerin Geliflimi Üzerine Etkisi, XXXIV. Ulusal Hematoloji Kongresi 2008 zmir. 7. Çetinkaya DU, K l ç E, Haznedaro lu C, Kirazl fi, F rat HC, Ankaferd Blood Stopper (ABS) in, n Vitro Ortamda Osteosarkom (Saos-2) Hücre Dizilerine Olan Anti-Kanser Aktivitesi, XXXIV. Ulusal Hematoloji Kongresi 2008 zmir. 8. Göker H, Çetinkaya DU, K l ç E, Haznedaro lu C, Kirazl fi, F rat HC, Ankaferd Blood Stopper (ABS) in n Vitro Ortamda Osteosarkom (Saos-2) Hücre Dizilerine Olan Anti-Kanser Aktivitesi 34. Ulusal Hematoloji Kongresi Akal n, Haznedaro lu C, Göker H, Düflük Doz Ankaferd in nsan Lenfoid Neoplastik Hücre Dizileri (B-CLL ve Burkitt All) Üzerine n Vitro Etkileri, data on file. 10. K l ç E, Çetinkaya DU, Haznedaro lu C, Turgut M, Aksu S, Kirazl fi, Göker H, Ankaferd Blood Stopper n (ABS) n Vitro Ortamda Mezenkimal Kök Hücrelerin Geliflimi Üzerine Etkisi, 34. Ulusal Hematoloji Kongresi Karaman K, Celep B, Bostanc EB, Teke Z, Ulafl M, Dinçer N, Kurt M, Ako lu M, Effects of Ankaferd Blood Stopper on Pancreatic Fluid: An in Vitro Study, ANZ Journal of Surgery Huri E, Haznedaro lu, Akgül KT, Astarc M, Üstün H, Germiyano lu C, Biphasic Effects of Ankaferd Bloodstopper on Renal Tubular Apoptosis in the Rat Partial Nephrectomy Model Representing Distinct Levels of Hemorrhage, Phytotherapy Research 2009.

2 13. Bilgili H, Captu O, Koflar A, Kurt M, Kekilli M, Shorbagi A, Kurt OK, Özdemir O, Göker H, Haznedaro lu C, Oral Systemic Administration of Ankaferd Blood Stopper has no Short-Term Toxicity in an n Vivo Rabbit Experimental Model, XXII Congress The International Society on Thrombosis and Haemostasis Pwee KH, Health Technology Assessment in Singapore Int. J. of Technology Assessment in Health Care, 25: Supplement 1 (2009), Huri E, Haznedaroglu IC, Akgula T, Astarcic M, Ustunc H, Germiyanoulua C. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage.saudi Med J 2010; Vol. 31 (8). 16. Demiralp DO, Haznedaroglu IC, Akar N ve ark. Functional proteomic analysis of Ankaferd (R) Blood Stopper. Turkish J Hematology. 2010; 27 (2): PREKL N K ÇALIfiMALAR 1. Koflar A, Cipil HS, Kaya A, Uz Burak, Haznedaro lu C, Göker H, Özdemir O, Erçetin S, Kirazl fi, F rat HC, The Efficacy of Ankaferd Blood Stopper in Antithrombotic Drug-Induced Primary and Secondary Hemostatic Abnormalities of a Rat-Bleeding Model, Blood Coagulation and Fibrinolysis 2009, 20: Bilgili H, Çaptu Ö, Koflar A, Kurt M, Kekilli M, Shorbagi A, Kurt OK, Özdemir O, Göker H, Haznedaro lu C, Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an In Vivo Rabbit Experimental Model, CLIN APPL THROMB HEMOST OnlineFirst, Pulished on July 14, Huri E, Akgül T, Ayy ld z A, Üstün H, Germiyano lu C, Hemostatic Role of a Folkloric Medicinal Plant Extract in a Rat Partial Nephrectomy Model: Controlled Experimental Trial, The Journal of Urology Vol. 181, , May Tokgöz H, Karakaya K, Hanc V, Abduflo lu M, Erol B, Türksoy Ö, Akduman B, Mungan NA, Protective Value of a Folkloric Medicinal Plant Extract Against Mortality and Hemorrhage in a Life-threatening Renal Trauma Model, Article in Press Basic and Translational Science Cipil HS, Koflar A, Kaya A, Uz B, Haznedaro lu C, Göker H, Özdemir O, Koro lu M, Kirazl fi, F rat HC, In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin, Clinical and Applied Thrombosis/Hemostasis Volume 15 Number 3 June 2009, Akgül T, Huri E, Ayy ld z A, Üstün H, Germiyano lu C, Haemostatic and Histopathological Effects of Ankaferd Blood Stopper, on Penile Cavernosal Tissue in Rats, International Journal of Hematology and Oncology Bilgili H, Koflar A, Kurt M, Onal K, Göker H, Çaptu Ö, Shorbagi A, Turgut M, Kekilli M, Kurt OK, Kirazl fi, Aksu S, Haznedaro lu C, Med Princ Pract 2009; 18: Tokgöz H, Karakaya K, Hanc V, Abduso lu M, Erol B, Türksoy O, Akduman B, Mungan NA, Protective Value of a Folkloric Medicinal Plant Extract Against Mortality and Hemorrhage in Acute Renal Trauma Model in Heparinized Rats, EAU 3RD North Eastern European Meeting (NEEM)/European Urology Supplements 8 (2009) Germiyano lu C, Huri E, Akgül T, Ayy ld z A, Üstün H, In-Vivo Haemostatic Effect of Ancaferd Bloodstopper in Rat Major Renal Trauma Model: Controlled Trial of Novel Haemostatic Agent, EAU 3RD North Eastern European Meeting (NEEM)/European Urology Supplements 8 (2009) K l ç Ö, Gönen M, Acar K, Yurdakul T, Avunduk MC, Esen HH, Öz M, Haemostatic Role and Histopathological Effects of a New Haemostatic Agent in a Rat Bladder Haemorrhage Model: An Experimental Trial, BJU Int. J. Compilation Karakaya K, Uçan HB, Taflç lar Ö, Emre AU, Çakmak GK, Irkorucu O, Ankaral H, Cömert M, Evaluation of a New Hemostatic Agent Ankaferd Blood Stopper in Experimental Liver Laceration, Journal of Investigative Surgery, 22, , Trakyal G, Öztoprak O, Plant Extract Ankaferd Blood Stopper Effect on Bond Strength, Angle Orthodontist, Vol 80, No 3, Eyi EGY, Yapar EA, Ar N, Mollamahmuto lu L, Haznedaro lu IC, In Vivo Hemostatic Effect of Ankaferd Blood Stopper in Rat Abdominal Bleeding Model, International Symposium on Pharmaceutical Sciences Ankara, Kalayc MU, Ero lu HE, Soylu A, Kubilay D, Sancak B, U urluo lu C, Erçin U, Koca Y, An Assesment of the Effect of Ancaferd Blood Stopper on Haemostasis and Histopathological Score in Experimental Liver Injury, Eur J Trauma Emerg Surg Kalayc MU, Kubilay D, Koca Y, Sancak B, Bahar B, Ero lu HE, Soylu A, U urluo lu C, Effect of Ankaferd Blood Stopper on Oxidative Stress in Experimental Liver Injury, Eur J Trauma Emerg Surg Huri E, Akgül T, Ayy ld z A, Üstün H, Germiyano lu C, Yerel T bbi Bitki Ekstresi Olan Ankaferd Blood Stopper Hemostatik Etkinli inin Rat Parsiyel Nefrektomi Modelinde De erlendirilmesi: Hayvan Deneyi, XXXIV. Ulusal Hematoloji Kongresi. 17. Huri E, Akgül T, Ayy ld z A, Üstün H, Germiyano lu C, Ankaferd Blood Stopper n Majör Renal Travmada Kanamay Durdurmaya Olan Etkinli inin De erlendirilmesi: Hayvan Deneyi, XXXIV. Ulusal Hematoloji Kongresi.

3 18. Akgül T, Huri E, Ayy ld z A, Üstün H, Germiyano lu C, Yerel T bbi Bitki Ekstresi Olan Ankaferd Blood Stopper n S çan Penil Fraktür Modeli Üzerine Olan Histopatalojik Etkisi: Deneysel Çal flma, XXXIV. Ulusal Hematoloji Kongresi. 19. Demircan S, fller C, Çakarer S, Çebi Z, Keskin C, Soluk M, Ankaferd Blood Stopper n Erken Dönem Kemik Dokusu yileflmesi Üzerine Etkileri: S çanlar Üzerinde Deneysel Çal flma, XXXIV. Ulusal Hematoloji Kongresi. 20. Demircan S, fller C, Çakarer S, Yüzbafl o lu E, Soluk M, Çebi Z, Keskin C, Ankaferd Blood Stopper n Erken Dönem Kemik Dokusu yileflmesi Üzerine Etkileri; S çanlar Üzerinde Deneysel Çal flma, Oral Cerrahi Derne i VIII. Uluslararas Bilimsel Kongresi. 21. Yeflilada AK, Tatl dede S, Sümer O, fiirvan S, Sak z D, Yeflilo lu N, Bafl L, Ankaferd Blood Stopper Hemostatic Ajan n Sekonder Yara yileflmesi Üzerine Etkisinin Ratlarda De erlendirilmesi: Deneysel Çal flma, Ankaferd Bilimsel Perspektif ve Temel Klinik Veriler Kitab. 22. Durmufl H, ph on Ankaferd ph is the Measure of Theacidity or Alcalinity of a Solutions, data on file. 23. Duz E,Aslan L,Alkan I,ve ark. The Investigation on the Effect of the Vegetal Origin Ankaferd BloodStopper in Experimental Intra-Abdominal Surgery Over Rabbits. J Animal& Veterinary Advances. 2010; 9(10): Kurtaran H,Ark N,Ugur KS ve ark. Curr Ther Res-Clin&Experimental.2010; 71( 2): Kalcioglu MT,Bayindir T,Iraz M ve ark. The Effects of a New Hemostatic Agent on Hearing in Rats. J Int Advanced Otology. 2010; 6 (2): Aysan E, Bektas H, Ersoz F, Sari S, Kaygusuz A, Huq GE. Ability of the ankaferd blood stopper to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med 2010; 3 (3): Kalcioglu MT, Bayindir T, Iraz M, Kaya S, Can S.The Effects of a New Hemostatic Agent on Hearing in Rats.Int. Adv. Otol. 2010; 6: (2) Düz E, Aslan L, Alkan, Bayram, Kaya A, Ayhan H, Özer E, The Investigation on the Vegetal Origin Ankaferd Blood Stopper in Experimental Intra-Abdominal Surgery Over Rabbits, Journal of Animal and Veterinary Advance 9 (10): , Tokgöz H, Hanc V, Erol B, Akduman B, Karakaya K, Hakimo lu S, Mungan NA, Postoperative Adhesions after Application of Topical Hemostatic Agents: Outcomes in a Partial Nephrectomy Model, The Journal of Urology Vol. 183 No:4 Supplement Sunday May 30, Kalayci MU, Soylu A, Ero lu HE, Kubilay D, Sancak B, U urluo lu C, Erçin U, Koca Y, Karatepe O, Effect of Ankaferd Blood Stopper on Hemostasis and Histopathological Score in Experimental Liver Injury, Bratisl Lek Listy 2010; 111 (4): Isler SC ve ark. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci. 2010; 18 (4): Aysan E ve ark. Ability of the ankaferd blood stopper to prevent parenchymal bleeding in an experimental hepatic trauma model. Int J Clin Exp Med 2010; 3 (3): Cömert M ve ark. Does intraabdominal use of Ankaferd Blood Stopper cause increased intraperitoneal adhesions? Ulus Travma Acil Cerrahi Derg 2010;16 (5): NFEKS YON 1. Akkoç N, Akçeik M, Haznedaro lu, Göker H, Aksu S, Kirazl S, F rat H, In Vitro Anti-Bacterial Activities of Ankaferd Blood Stopper, Int Jnl Lab. Hem. 2008, 30 (Suppl. 1) F flg n NT, Çayc YT, Çoban AY, Özatl D, Tanyel E, Durup nar B, Tülek N, Antimicrobial Activity of Plant Extract Ankaferd Blood Stopper, Fitoterapia 80 (2009) Sar bafl Z, fiener B, Haznedaro lu C, Hasçelik G, Kirazl fi, Göker H, Antimicrobial Activity of Ankaferd Blood Stopper Against Nosocomial Bacterial Pathogens, Cent Eur J Med Akkoç N, Akçelik M, Haznedaro lu C, Göker H, Turgut M, Aksu S, Kirazl fi, F rat HC, In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract, Türkiye Klinikleri J Med Sci 2009; 29 (2). 5. Sar bafl Z, fiener B, Haznedaro lu C, Hasçelik G, Kirazl fi, Göker H, Hemostatik Bir Ajan Olan Ankaferd in Anti-Bakteriyel Etkinli inin Araflt r lmas, 10. Ulusal ç Hastal klar Kongresi Antalya Akkoç N, Akçelik M, Haznedaro lu C, Kirazl fi, F rat HC, Ankaferd Proteomix Besin Takviyesi ve Ankaferd S r Kozmetik Preparat n n Vitro Anti-Mikrobiyal Etkinliklerinin Karfl laflt r lmas, 10. Ulusal ç Hastal klar Kongresi Antalya Akkoç N, Akçelik M, Haznedaro lu C, Göker H, Turgut M, Aksu S, Kirazl fi, F rat HC, Ankaferd T bbi Bitki Ekstresinin n Vitro Anti-Fungal Etkinli inin Tan mlanmas, XXXIV. Ulusal Hematoloji Kongresi. 8. Akkoç N, Akçelik M, Haznedaro lu C, Göker H, Turgut M, Aksu S, Kirazl fi, F rat HC, Ankaferd T bbi Bitki Ekstresinin n Vitro Anti-Fungal Etkinli inin Tan mlanmas, 34. Ulusal Hematoloji Kongresi Ekim 2008.

4 9. Ery lmaz M, Yapar EA, Yapar Eyi EG, Ak n A, Haznedaro lu C, Antibacterial Activity of Ankaferd Blood Stopper Against Clinical Isolates of Staphylococcus Aureus, J Gynecol-Obstet Neonatal 2008; 3: Sar bafl Z, fiener B, Hasçelik G, Haznedaro lu C, Kirazl fi, Göker H, Ankaferd T bbi Bitki Ekstresinin Hastane nfeksiyonlar na Karfl Etkinli i, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab. 11. F flg n NT, Çayc YT, Çoban AY, Özatl D, Tanyel E, Durup nar B, Tülek N, Ankaferd Blood Stopper n Antimikrobiyal Etkinli i, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab. 12. Berktafl M, Yaman G, Ayhan H, Aksakal A, Güdücüo lu H, Öztürk Ö, Parlak M, Ankaferd Blood Stopper; Ayn Zamanda deal Bir Antibiyotik Öncülü Mü?, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab. 13. Sar bafl Z, fiener B, Haznedaro lu C, Hasçelik G, Kirazl fi, Göker H, Hemostatik Bir Ajan Olan Ankaferd in Anti-Bakteriyel Etkinli inin Araflt r lmas, 10. Ulusal ç Hastal klar Kongresi Akkoç N, Akçelik M, Haznedaro lu C, Kirazl fi, F rat HC, Ankaferd Proteomix Besin Takviyesi ve Ankaferd S r Kozmetik Preparat n n Vitro Anti-Mikrobiyal Etkinliklerinin Karfl laflt r lmas, 10. Ulusal ç Hastal klar Kongresi Sar bafl Z, fiener B, Hasçelik G, Ankaferd in Hastane nfeksiyon Etkenleri Üzerine n Vitro Etkileri, 34. Ulusal Hematoloji Kongresi Ekim Bodur H, K r m Kongo Kanamal Atefli Hastalar nda Lokal Ankaferd Blood Stopper Deneyimi, 34. Ulusal Hematoloji Kongresi Ekim Ramesh, Putheti and Okigbo, R.N., Effects of Plants and Medicinal Plant Combinations as Anti-Infectives, African Journal of Pharmacy and Pharmacology Vol. 2 (7). pp , September, KL N K GÖZLEM ve ÇALIfiMALAR 1. Haznedaro lu C, Hemostatic Effects of Ankaferd Blood Stopper in Bleeding, ICOS Huri E, The Application of Ankaferd Blood Stopper, a Novel Hemostatic Agent, in Urologic Surgery as a First Experiences and the Experimental Trials in Urology, ICOS Baykul T, Alano lu G, Koçer G, Use of Ankaferd Blood Stopper as a Hemostatic Agent: A Clinical Experience, The Journal of Contemporary Dental Practice, Volume 11, No. 1, January 1, Kurt M, Tandem Oral, Rectal and Nasal Administrations of Ankaferd Blood Stopper to Control Profuse Bleeding Leading to Hemodynamic nstability, American Journal of Emergency Medicine (2009) 27, 631.e1-631.e2. 5. Öner AF, Kaya A, Temel H, Melek M, Karaman K, Epçapan S, Be er B, Ayhan H, yayg n Damar çi P ht laflmas Saptanan Bir Hastada Yüzeyel Ankaferd Blood Stopper Kullan m, Türk Pediatri Arflivi Dergisi. 6. Öner AF, Do an M, Kaya A, Sal E, Bektafl MS, Yeflilmen O, Ayhan H, Aç kgöz M, New Coagulant Agent (Ankaferd Blood Stopper) for Open Hemorrhages in Hemophilia With Inhibitor, Clin Appl Thromb Hemost OnlineFirst, Published on June 14, Sönmez M, Baltac o lu E, Saraç Ö, Erkut N, The Use of Ankaferd Blood Stopper in a Patient With Glanzmann s Thrombasthenia With Gingival Bleeding, Blood Coagulation and Fibrinolysis Erçetin S, Haznedaro lu C, Kurt M, Önal K, Aktafl A, Kurt ÖK, Göker H, Özdemir O, Kirazl fi, F rat HC, Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery, Uluslararas Hematoloji-Onkoloji Dergisi Number:1 Volume:20, Turgut M, Arslan S, Çelebi N, Pamuk F, Haznedaro lu C, Demircan S, Aktafl A, Kalan I, Göker H, Atalar E, Kirazl fi, F rat HC, Kritik Kanamalar n Kontrolünde Ankaferd Blood Stopper (ABS) Uygulamalar, 10. Ulusal ç Hastal klar Kongresi Antalya Teker AM, Korkut AY, Kahya V, Gedikli O, Prospective, Randomized, Controlled Clinical Trial of Ankaferd Blood Stopper in Patients With Acute Anterior Epistaxis, Eur Arch Otorhinolaryngol Al B, Y ld r m C, Çavdar M, Zengin S, Büyükaslan H, Kalender ME, Effectiveness of Ankaferd Blood Stopper in the Topical Control of Active Bleeding Due to Cutaneous-Subcutaneous Incisions, Saudi Med J 2009; Vol. 30 (12): Teker AM, Korkut AY, Gedikli O, Kahya V, Prospective, Controlled Clinical Trial of Ankaferd Blood Stopper in Children Undergoing Tonsillectomy, International Journal of Pediatric Otorhinolaryngology 73 (2009) Bodur H, Öngürü P, Ak nc E, Eren SS, Gözel G, Bafltu A, Y lmaz S, K r m Kongo Kanamal Atefli Hastalar nda Lokal Ankaferd Blood Stopper Deneyimi, 34. Ulusal Hematoloji Kongresi zmir, Turgut M, Tutkun F, Çelebi N, Mu lal M, Göker H, Haznedaro lu C, Topical Ankaferd Blood Stopper in the Management of Critical Bleedings Due to Hemorrhagic Diathesis, Uluslararas Hematoloji-Onkoloji Dergisi Pamuk F, Çetinkaya BO, Kelefl GC, Ball U, Turgut M, Phase I Periodontal Therapy With Ankaferd Blood Stopper in Patients With Hemorrhagic Disorder, Journal of Clinical Periodontology Volume 36 Issue s9, , Çetinkaya BO, Kelefl GC, Pamuk F, Ball U, The Role of Ankaferd Blood Stopper in Phase I Periodontal Therapy, Journal of Clinical Periodontology Volume 36 Issue s9, , 2009.

5 17. Ak G, Çak r O, Kazanc o lu HO, K l ç S, Erçetin S, Zülfikar B, Is Ankaferd Blood Stopper an Alternative Coagulation Method for Hemophiliac Patients?, Oral Diseases (2008) 14 (Suppl. 1), Do an OF, Özyurda U, Uymaz OK, Erçetin S. Haznedaro lu C, New Anticoagulant Agent for CABG Surgery, European Journal of Clinical Investigation Vol 38, Kurt M, Kaçar S, Önal K, Akdo an M, Haznedaro lu C, Ankaferd Blood Stopper as an Effective Adjunctive Hemostatic Agent for the Management of Life-Threatening Arterial Bleeding of the Digestive Tract, Endoscopy 2008; 40: E Turhan N, Kurt M, Akdo an M, Arhan M, Kekilli M, Haznedaro lu C, Topical Ankaferd Blood Stopper Administration to Bleeding Gastrointestinal Carcinomas Can Control Local Hemorrhage and Decrease Tumor Vascularization, J Thromb Haemost Volume 7, Supplement Tuncer, Do anay L, Öztürk O, Instant Control of Fundal Variceal Bleeding With a Folkloric Medicinal Plant Extract: Ankaferd Blood Stopper, Gastrointestinal Endoscopy Özaslan E, Purnak T, Y ld z A, Akar T, Avc o lu U, Haznedaro lu C, The Effect of Ankaferd Blood Stopper on Severe Radiation Colitis, Endoscopy 2009; 41: E Kurt M, Akdo an M, bifl M, Haznedaro lu C, Ankaferd Blood Stopper for Gastrointestinal Bleeding, Journal of Investigative Surgery, 23, 1-1, Özaslan E, Purnak T, Y ld z A, Haznedaro lu C, A New Practical Alternative for Tumoural Gastrointestinal Bleeding: Ankaferd Blood Stopper, Digestive and Liver Disease Kurt M, Akdo an M, Onal K, Kekilli M, Arhan M, Shorbagi A, Aksu S, Kurt ÖK, Haznedaro lu C, Endoscopic Topical Application of Ankaferd Blood Stopper for Neoplastic Gastrointestinal Bleeding: A Retrospective Analysis, Digestive and Liver Disease Arslan S, Haznedaro lu C, Öz B, Göker H, Endobronchial Application of Ankaferd Blood Stopper to Control Profuse Lung Bleeding Leading to Hypoxemia and Hemodynamic Instability, Respiratory Medicine CME (2009) 2, Turhan N, Kurt M, Shorbagi A, Akdo an M, Haznedaro lu C, Topical Ankaferd Blood Stopper Administration to Bleeding Gastrointestinal Carcinomas Decreases Tumor Vascularization, The American Journal of Gastroenterology Arslan S, Yeflil Y, Ülger Z, Cankurtaran M, Göker H, Haznedaro lu C, Yafll Bir Hastada Yumuflak Doku Travmas na Ba l Geliflen Yara yileflmesinde Ankaferd, Akad Geriatri 2010; 2: Purnak T, Özaslan E, Y ld z A, Haznedaro lu C, Upper Gastrointestinal Bleeding in a Patient with Defective Hemostasis Succesfully Treated with Ankaferd Blood Stopper, Phytotherapy Research Koray M, Ergün S, Saruhano lu A, Tanyeri H, Use of a Local Haemostatic Agent Ankaferd Blood Stopper After Surgical Excision of Eruption Cyst: A Case Report, Free Papers-Poster Presentation doi: /j.ijom Çal flkan Ü, Albayrak CU, Ac payaml C, Afibrinojenemili Bir Vakada Cilt Kesisine Ba l Kanaman n Ankaferd ile Durdurulmas, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Çal flkan Ü, Albayrak CU, Ac payaml C, Tar Sendromlu Bir Vakada Difl Çekimine Ba l Kanaman n Ankaferd ile Durdurulmas, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Çal flkan Ü, Albayrak CU, Ac payaml C, Glanzmann Trombastenili Bir Vakada Difl Çekimi ve Sünnete Ba l Kanaman n Ankaferd ile Durdurulmas, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Erçetin S, Haznedaro lu C, Kurt M, Önal K, Aktafl A, Göker H, Özdemir O, Kirazl fi, F rat HC, A z, Difl ve Çene Cerrahisinde Ankaferd Blood Stopper in Etkinli i ve Güvenilirli i, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Alano lu G, Koçer G, Baykul T, Ankaferd Blood Stopper Deneyimimiz, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Ak G, Zülfikar B, Erçetin S, K l ç S, Hemofili Hastalar nda Difl Çekimi Sonras nda Ankaferd Blood Stopper Kullan m, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Çipil H, Koflar A, Haznedaro lu C, Uz B, Göker H, Özdemir O, Kirazl fi, Aspirin, Düflük Molekül A rl kl Heparin, Varfarin Alan Ratlarda Ankaferd Blood Stopper (ABS) nin Topikal Kullan m n n Amputasyon ve Kuyruk Modelinde Kanama Süresi ve Kanama Miktar na Etkisinin Araflt r lmas, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Öner AF, Do an M, Kaya A, Sal E, Bektafl MS, Aktar F, Yeflilmen O, Ayhan H, Sünnet Edilme Yerinde Durdurulamayan Kanamas Olan nhibitörlü Hemofili A Olgusunda Ankaferd Blood Stopper ile Dramatik Cevap, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Öner AF, Kaya A, Temel H, Melek M, Karaman K, Epçaçan S, Be er B, Ayhan H, Dissemine ntravasküler Koagulasyonlu Bir Hastada Yüzeyel Ankaferd Blood Stopper Kullan m : Bir Olgu Sunumu, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: Canatan D, Savafl Ç, Kubulu AE, Çubukçu E, An l H, Duman H, Gürtuna A, nhibitörlü Hemofili A Hastas nda RFVIIA ve Ankaferd Kullan m, XXXIV. Ulusal Hematoloji Kongresi Bildiri Özetleri Kitab Bildiri: 374.

6 41. Karabulut H, Acar B, Babademez M, Günbey E, Karaflen R, BP-103-Alt Konka Rezeksiyonlar ndan Sonra Ankaferd Blood Stopper li Merocel Uygulamas, 30. Türk Ulusal Kulak Burun Bo az Bafl Boyun Cerrahisi Kongresi Antalya, Ekim Ak G, Çak r O, Kazanc o lu HO, K l ç S, Erçetin S, Zülfikar B, Use of Ankaferd Blood Stopper After Tooth Extraction on Hemophiliac Patients, 9. EOAM-European Association of Oral Medicine 2008 Congress. 43. Aktafl A, Er N, Kirifl S, Haznedaro lu C, Hemorajik Diyatezli ki Hastada Ankaferd Blood Stopper ile Tedavi, Türk Oral ve Maksillofasiyal Cerrahi Derne i 15. Uluslararas Kongresi 2008 Antalya. 44. Aktafl A, Er N, Onur MA, Zeybek D, Korkusuz P, Ankaferd Blood Stopper Bitki Ekstresinin Difl Çekim Soketi yileflmesinin Erken Dönemine Etkisinin ncelenmesi, data on file. 45. Alano lu G, Koçer G, Baykul T, Ankaferd Blood Stopper Deneyimimiz, 34. Ulusal Hematoloji Kongresi Ekim Karabulut H, Acar B, Babademez MA, Günbey E, Karaflen RM, Alt Konka Rezeksiyonlar ndan Sonra Ankaferd Blood Stopper li Tampon Uygulamas, 30. Türk Ulusal KBB ve Bafl Boyun Cerrahisi Kongresi / 4. Türk-Amerikan KBB Bafl Boyun Cerrahisi Ortak Toplant s. 47. Turgut M, Arslan S, Öz B, Atalar E, Haznedaro lu C, Aktafl A, Göker H, Kirazl fi, F rat HC, Kritik Kanamalar n Kontrolünde Ankaferd Blood Stopper (ABS) Uygulamalar, 10. Ulusal ç Hastal klar Kongresi Coflkun F, Pekbüyük K, Akküçük H, Ataman DK, Haznedaro lu C, Effective Control of the Bleeding From an Arteriovenous Malformation of the Lower Extremity Via Topical Ankaferd Blood Stopper Tampone: A Case Raport, 5th. Europe An Congress / on Emergency Medicine Batur AF, Tunç L, Endoürolojide Kullan lan Hemostatik Materyaller, Endoüroloji Bülteni. 50. Ozaslan E, Purnak T, Yildiz A ve ark. The Effect of a New Hemostatic Agent for Difficult Cases of Non-variceal Gastrointestinal Bleeding: Ankaferd Blood Stopper. HEPATO-GASTROENTEROLOGY.PY 2010; 57 (98): Karaman K, Bostanci EB, Ercan M. Topical Ankaferd Application to Presacral Bleeding due to Total Mesorectal Excision in Rectal Carcinoma. J Invest Surg Jun; 23 (3): Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology Mar-Apr; 57 (98): Kurt M, Onal I, Akdogan M, ve ark. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol Jun; 24 (6): Purnak T, Ozaslan E, Beyazit Y, Haznedaroglu IC. Upper Gastrointestinal Bleeding in a Patient With Defective Hemostasis Successfully Treated with Ankaferd Blood Stopper. Phytother Res Jul 30. [Epub ahead of print]. 55. Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd blood stopper. Hepatogastroenterology Mar-Apr; 57 (98): Sonmez M, Baltacioglu E, Sarac O, Erkut N.The use of Ankaferd blood stopper in a patient with Glanzmann's thrombasthenia with gingival bleeding.blood Coagul Fibrinolysis Jun; 21 (4): Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd BloodStopper: a novel indication (with). Gastrointest Endosc Apr 22. [Epub ahead of print] 58. Huri E, Akgül T, Ayy ld z A, Germiyano lu C, Hemostasis in Retropubic Radical Prostatectomy With Ankaferd Blood Stopper: A Case Report, Kaohsiung J Med Sci 2009; 25: 445-7). 59. F nd kç o lu K, F nd kç o lu F, Ankaferd Kanama Durdurucunun Plastik Cerrahi Prati inde Kullan m Alanlar : Olgu Sunumlar Turk Plast Surg 2009; 17 (3). 60. Beyaz t Y, Köklü S, Akbal E, Kurt M, Kekilli M, Haznedaro lu C, Successful Treatment of Endoscopic Sphincterotomy-Induced Early Hemorrhage With Application of Ankaferd Blood Stopper, Gastrointestinal Endoscopy Kurt M ve ark. Ankaferd Blood Stopper for Gastrointestinal Bleeding. Journal of Investigative Surgery 2010; 23, Özaslan E ve ark. Bleedıng due to slıppage of elastıc band durıng varıceal lıgatıon: successful use of Ankaferd blood stopper. Indian J Gastroenterol DOI /s y. KONGRE ve B L MSEL TOPLANTILAR 1. Haznedaro lu C, Molecular Basis of the Pleitropic Effects of Ankaferd Blood Stopper, Third International Congress of Molecular Medicine May 5-8, 2009, Istanbul, Turkey. 2. Haznedaro lu C, Hemostatic Effects of Ankaferd Blood Stopper in Bleeding, ICOS Huri E, The Application of Ankaferd Blood Stopper, a Novel Hemostatic Agent, in Urologic Surgery as a First Experiences and the Experimental Trials in Urology, ICOS-2009.

7 4. Pwee KH, Health Technology Assessment in Singapore, Int J of Technology Assessment in Health Care, 25: Supplement 1 (2009), Okumus M, Yüksel KZ, Özba D, Ç ral k H, Y lmaz Z, Gümüflalan Y, Efficiency of the Medicinal Plant Extract Ankaferd Blood Stopper in Deep Hemorrhage and Histopathological Changes in Tissue Level in Rats, 10th Congress of European Association of Clinical Anatomy 2009 Istanbul Turkey. 6. fller SC, Demircan S, Çakarer S, Çebi Z, Keskin C, Soluk M, Yüzbafl o lu E, The Effects of Folkloric Medicinal Plant Extract Ankaferd Blood Stopper on Early Bone Healing, International Congress of Society of Turkish Oral Surgery, Bodrum Turkey fller SC, Demircan S, Çakarer S, Çebi Z, Keskin C, Soluk M, Yüzbafl o lu E, The Effects of Folkloric Medicinal Plant Extract Ankaferd Blood Stopper on Healing of Post Extraction Sockets, International Congress of Turkish Oral Maxillofacial Surgery Society, Antalya Turkey Ak G, Çak r O, Kazanc o lu HO, K l ç S, Erçetin S, Zülfikar B, Is Ankaferd Blood Stopper an Alternative Coagulation Method for Hemophiliac Patients?, Oral Diseases. 9. Haznedaro lu I. Bir Türk lacı: Ankaferd". Fatih Üniversitesi Tıp Fakültesi. 1.Uluslarası Ö renci Kongresi 2010 Ankara. B L MSEL TEZ ARAfiTIRMALARI 1. Çipil Hfi, Aspirin, Düflük Molekül A rl kl Heparin, Varfarin Alan Ratlarda Ankaferd Blood Stopper (ABS) nin Topikal Kullan m n n Amputasyon ve Kuyruk Modelinde Kanama Süresi ve Kanama Miktar na Etkisinin Araflt r lmas, Usmanl k Tezi Güler B, Ankaferd Blood Stopper in Nörotoksik Etkisi, Uzmanl k Tezi DERG ve DÖKÜMANLAR 1. Haznedaro lu C, Sa l kta Ankaferd Devrimi, Patent Dünyas Y l:9 Say : 28 K fl K TAPLAR 1. F rat HC, Özdemir O, Koflar A, Göker H, Haznedaro lu C, Ankaferd Blood Stopper Annual Review of Arkaferd 08-09, Naviga Scientific Publication 3 Istanbul Göker H, Haznedaro lu C, Erçetin S, Ankaferd Blood Stopper Product Literature Summaries. B L MSEL RAPORLAR 1. Bozkurt NB, Akyüz HÖ, Cytotoxicity Test Report Bozkurt TE, Ekinci D, Irr tation Test Report Özkan MH, Bozkurt TE, Bozkurt NB, Ekinci D, Sensitization Test Report Akman Ü, Kirazl fi, Eraslan N, Haemostatic Lab Test Reports: Search for a Mechanism Underlying the Haemostatic Effects of Ankaferd Blood Stopper 2007.

Effects of Ankaferd hemostat on the synovial fluid of patients with osteoarthritis

Effects of Ankaferd hemostat on the synovial fluid of patients with osteoarthritis Original Article Turk J Med Sci 2012; 42 (5): 768-772 TÜBİTAK E-mail: medsci@tubitak.gov.tr doi:10.3906/sag-1108-20 Effects of Ankaferd hemostat on the synovial fluid of patients with osteoarthritis Mehmet

More information

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Blood products and pharmaceutical emergencies

Blood products and pharmaceutical emergencies Blood products and pharmaceutical emergencies Kasey L. Bucher PharmD, BCPS Clinical Specialist, Emergency Medicine Mercy Health Saint Mary s September 12, 2013 Disclosures None significancemagazine.com

More information

New Anticoagulants: When and Why Should I Use Them? Disclosures

New Anticoagulants: When and Why Should I Use Them? Disclosures Winship Cancer Institute of Emory University New Anticoagulants: When and Why Should I Use Them? Christine L. Kempton, MD, MSc Associate Professor of Pediatrics and Hematology and Medical Oncology Hemophilia

More information

Tıpta Uzmanlık Tezi: Akut lenfoblastik lösemi ve kronik myeloid lösemi'de imatinib mesilat ile "hedeflenmiş tedavi"

Tıpta Uzmanlık Tezi: Akut lenfoblastik lösemi ve kronik myeloid lösemi'de imatinib mesilat ile hedeflenmiş tedavi 1 Adı Soyadı : Ali İbrahim Shorbagi Doğum Tarihi : 30.06.1979 Unvanı : Uzman doktor (İç hastalıkları ve Gastroenteroloji) Öğrenim Durumu: Derece Alan Üniversite Yıl Y. Lisans İç Hastalıkları Hacettepe

More information

WHAT TURKEY EXPECTED AND FOUND FROM THE CUSTOMS UNION IN THE TWENTIETH ANNIVERSARY

WHAT TURKEY EXPECTED AND FOUND FROM THE CUSTOMS UNION IN THE TWENTIETH ANNIVERSARY International Journal of Business and Management Studies, CD-ROM. ISSN: 2158-1479 :: 05(01):117 126 (2016) WHAT TURKEY EPECTED AND FOUND FROM THE CUSTOMS UNION IN THE TWENTIETH ANNIVERSARY smet Ate and

More information

Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery

Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Prostate Cancer Your prostate is a walnut-sized gland that is part of the male reproductive system. The prostate

More information

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery

Stop the Bleeding: Management of Drug-induced Coagulopathy. Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Stop the Bleeding: Management of Drug-induced Coagulopathy Stacy A. Voils, PharmD, BCPS Critical Care Specialist, Neurosurgery Objectives Discuss contemporary management of warfarin reversal in patients

More information

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation

Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Guideline Statement for the Treatment of Disseminated Intravascular Coagulation Introduction Though a rare occurrence in the perioperative setting, disseminated intravascular coagulation (DIC) is a syndrome

More information

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery

XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery XARELTO (rivaroxaban tablets) in Knee and Hip Replacement Surgery Fast Facts: XARELTO is a novel, once-daily, oral anticoagulant recently approved in the United States for the prevention (prophylaxis)

More information

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN)

USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) USE AND INTERPRETATION OF LABORATORY COAGULATION TESTS IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals:

More information

PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande

PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL

More information

Appendix G - Identification and Selection of Studies

Appendix G - Identification and Selection of Studies FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies

More information

SLAUGHTER AND CARCASS TRAITS OF NATIVE GEESE REARED IN MUŞ PROVINCE

SLAUGHTER AND CARCASS TRAITS OF NATIVE GEESE REARED IN MUŞ PROVINCE Lucrări ştiinţifice Zootehnie şi Biotehnologii, vol. 42 (2) (2009), Timişoara SLAUGHTER AND CARCASS TRAITS OF NATIVE GEESE REARED IN MUŞ PROVINCE ÎNSUŞIRILE LA SACRIFICARE ŞI ALE CARCASEI LA GÂŞTELE LOCALE

More information

Damage Control in Abdominal Trauma

Damage Control in Abdominal Trauma Damage Control in Abdominal Trauma Steven Stylianos, MD Surgeon-in-Chief, Morgan Stanley Children s Hospital Rudolph Schullinger Professor of Surgery, Columbia University College of Physicians & Surgeons

More information

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies

More information

ERBEJET 2. The versatility of waterjet surgery: ERBEJET 2 with hybrid instruments WATERJET SURGERY

ERBEJET 2. The versatility of waterjet surgery: ERBEJET 2 with hybrid instruments WATERJET SURGERY ERBEJET 2 The versatility of waterjet surgery: ERBEJET 2 with hybrid instruments WATERJET SURGERY Gentle interventions in surgery and endoscopy Waterjet surgery with hybrid technology Waterjet surgery

More information

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding.

Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding disorders or haemorrhagic diatheses are a group of disorders characterised by defective haemostasis with abnormal bleeding. Bleeding may be spontaneous in the form of small haemorrhages into the

More information

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ET Departments of Gastroenterology and Hepatology,

More information

CURRICULUM VITAE. Degree Faculty / Department University Year

CURRICULUM VITAE. Degree Faculty / Department University Year CURRICULUM VITAE Name: GÖKÇE AYKOL ŞAHİN Title: Assistant Professor Education Degree Faculty / Department University Year DDS Faculty of Dentistry Istanbul University 2003 PhD Department of Periodontology

More information

FACULTY/DEPARTMENT: Pharmacy/Pharmaceutical Toxicology

FACULTY/DEPARTMENT: Pharmacy/Pharmaceutical Toxicology NAME: Aylin Üstündağ DATE AND PLACE OF BIRTH: 26.11.1977, Giresun FACULTY/DEPARTMENT: Pharmacy/Pharmaceutical Toxicology CURRENT POSITION: Research Assistant EDUCATION: Doctorate degree (Institution, Title,

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

Elenco dei periodici elettronici in Ovid Full text

Elenco dei periodici elettronici in Ovid Full text Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

ACCOUNTING EDUCATION IN THE HISTORY OF TURKISH REPUBL C

ACCOUNTING EDUCATION IN THE HISTORY OF TURKISH REPUBL C Prof.Dr. Ümit GÜCENME Res. Assist. Aylin POROY ARSOY ACCOUNTING EDUCATION IN THE HISTORY OF TURKISH REPUBL C Prof. Dr. Ümit GÜCENME Uludag University Faculty of Economics and Business Administration Res.

More information

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC

To Bridge or Not to Bridge. Periop Anticoagulation Management. Don Weinshenker, MD Ambulatory Care Denver VAMC To Bridge or Not to Bridge Periop Anticoagulation Management Don Weinshenker, MD Ambulatory Care Denver VAMC Financial Disclosure Information Nothing to report Periop AC Management Chronically anti-coagulated

More information

The Anti coagulated Patient: The Cardiologist s View. February 28, 2015

The Anti coagulated Patient: The Cardiologist s View. February 28, 2015 The Anti coagulated Patient: The Cardiologist s View February 28, 2015 Conflicts Dr. McMurtry has no conflicts to disclose. CanMeds Medical Expert (as Medical Experts, physicians integrate all of the CanMEDS

More information

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany

Preoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Preoperative drainage is always indicated in malignant CBD strictures PRO Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Background Jaundice is associated with high perioperative morbidity

More information

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU

Disclosure. New Agents for Treatment of DVT. Prevalence of DVT VTE. Normal Hemostasis 7/17/2015. Mark Oliver, MD, RVT, RPVI,FSVU New Agents for Treatment of DVT Disclosure PI Adopt and Amplify trials Mark Oliver, MD, RVT, RPVI,FSVU BMS and Pfizer Speaker VTE Venous Thromboembolism Recognized DVT s New : 170,000 Recurrent : 90,000

More information

MAIN LINE DENTAL IMPLANT CENTER

MAIN LINE DENTAL IMPLANT CENTER 1257 Lancaster Ave Berwyn, PA 19312 Tel: 610-722-5542 CHIUN-LIN (STEVEN), LIU D.D.S., D.M.D. School of Dental Medicine CURRICULUM VITAE Summer, 2012 Education: 1987-1993 D.D.S. Kaohsiung Medical University

More information

Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery

Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic

More information

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as

More information

48 th Annual Meeting. Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding. Terminology. Disclosure. Public Health Impact.

48 th Annual Meeting. Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding. Terminology. Disclosure. Public Health Impact. 48 th Annual Meeting Terminology Non-VKA Oral Anticoagulants: Prevention & Treatment of Bleeding Stacy A. Voils, PharmD, MS, BCPS Navigating the Oceans of Opportunity Target-specific oral anticoagulants

More information

CURRICULUM VITAE. Degree Faculty / Department University Year DDS Faculty of Dentistry Hacettepe University 2007

CURRICULUM VITAE. Degree Faculty / Department University Year DDS Faculty of Dentistry Hacettepe University 2007 CURRICULUM VITAE Name: UĞUR MERCAN Title: Assistant Professor Education Degree Faculty / Department University Year DDS Faculty of Dentistry Hacettepe University 2007 PhD Department of Oral and Ondokuz

More information

CURRICULUM VITAE. Hande Serdar Tülüce. İstanbul Bilgi University. Department of English Language Teacher Education. E-mail: hande.tuluce@bilgi.edu.

CURRICULUM VITAE. Hande Serdar Tülüce. İstanbul Bilgi University. Department of English Language Teacher Education. E-mail: hande.tuluce@bilgi.edu. CURRICULUM VITAE Hande Serdar Tülüce İstanbul Bilgi University Department of English Language Teacher Education E-mail: hande.tuluce@bilgi.edu.tr EDUCATION 2008-2012: Ph.D. Boğaziçi University, Foreign

More information

Out with the Old and in with the New? Target Specific Anticoagulants for Atrial Fibrillation

Out with the Old and in with the New? Target Specific Anticoagulants for Atrial Fibrillation Out with the Old and in with the New? Target Specific Anticoagulants for Atrial Fibrillation Goal Statement Pharmacists and technicians will gain knowledge in the use of target specific oral anticoagulants

More information

An Analysis of University Science Instructors Examination Questions According to the Cognitive Levels

An Analysis of University Science Instructors Examination Questions According to the Cognitive Levels An Analysis of University Science Instructors Examination Questions According to the Cognitive Levels Salih ÇEPN * Abstract The purpose of this study was to analyze exam questions prepared by university

More information

Impact of new (direct) oral anticoagulants in patient blood management

Impact of new (direct) oral anticoagulants in patient blood management Impact of new (direct) oral anticoagulants in patient blood management Yulia Lin, MD, FRCPC, CTBS Transfusion Medicine & Hematology, Sunnybrook Health Sciences Centre Dept of Laboratory Medicine & Pathobiology,

More information

Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009

Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009 Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy M. Arvanitakis SRBG June 2009 Outline Antibiotic prophylaxis during endoscopy Upper GI endoscopy Lower

More information

Kanıt: Klinik çalışmalarda ZYTIGA

Kanıt: Klinik çalışmalarda ZYTIGA mkdpk de Sonunda Gerçek İlerleme! Kanıt: Klinik çalışmalarda ZYTIGA Dr. Sevil Bavbek 5. Türk Tıbbi Onkoloji Kongresi Mart 214, Antalya Endocrine therapies Adrenals Testis Abiraterone Orteronel Androgen

More information

DATE: 06 May 2013 CONTEXT AND POLICY ISSUES

DATE: 06 May 2013 CONTEXT AND POLICY ISSUES TITLE: Low Molecular Weight Heparins versus New Oral Anticoagulants for Long-Term Thrombosis Prophylaxis and Long-Term Treatment of DVT and PE: A Review of the Clinical and Cost-Effectiveness DATE: 06

More information

LABORATORY DIAGNOSIS OF BLEEDING DISORDERS

LABORATORY DIAGNOSIS OF BLEEDING DISORDERS LABORATORY DIAGNOSIS OF BLEEDING DISORDERS Secondary Hemostasis CIRCULATORY SYSTEM Low volume, high pressure system Efficient for nutrient delivery to tissues Prone to leakage 2º 2 to endothelial surface

More information

Vitamin K Supplementation with Oral Anticoagulation

Vitamin K Supplementation with Oral Anticoagulation Vitamin K Supplementation with Oral Anticoagulation Farhad Kamali Institute of Cellular Medicine, Newcastle University Vitamin K Vitamin K belongs to a group of fat-soluble 2-methyl-1,4- naphthoquinone

More information

Curriculum Vitae. Clinical areas of special training and interest within Plastic, Reconstructive and Aesthetic Surgery include:

Curriculum Vitae. Clinical areas of special training and interest within Plastic, Reconstructive and Aesthetic Surgery include: Curriculum Vitae Name: ERSİN AKŞAM Address: Bilkent 1 Camlik Sit. B23-1 No:98 Cankaya Ankara/Turkey Telephone: +905336604580 E-Mail: ersinaksam@gmail.com MAJOR FIELDS OF INTEREST Plastic, Reconstructive

More information

Gastrointestinal Bleeding

Gastrointestinal Bleeding Gastrointestinal Bleeding Introduction Gastrointestinal bleeding is a symptom of many diseases rather than a disease itself. A number of different conditions can cause gastrointestinal bleeding. Some causes

More information

Surgical Treatment of Chronic Rhinosinusitis in. Children

Surgical Treatment of Chronic Rhinosinusitis in. Children Surgical Treatment of Chronic Rhinosinusitis in Children Fuad M. Baroody, M.D., F.A.C.S. Professor of Otolaryngology-Head and Neck Surgery and Pediatrics The University of Chicago Medicine and Biological

More information

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media

Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban

More information

Residency Competency and Proficiency Statements

Residency Competency and Proficiency Statements Residency Competency and Proficiency Statements 1. REQUEST AND RESPOND TO REQUESTS FOR CONSULTATIONS Identify needs and make referrals to appropriate health care providers for the treatment of physiologic,

More information

INTERNATIONAL MEDICAL COLLEGE

INTERNATIONAL MEDICAL COLLEGE INTERNATIONAL MEDICAL COLLEGE Joint Degree Master Program: Implantology and Dental Surgery (M.Sc.) Basic modules: List of individual modules Basic Module 1 Basic principles of general and dental medicine

More information

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery

Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement: The Use of VTED Prophylaxis in Foot and Ankle Surgery Position Statement There is currently insufficient data for the (AOFAS) to recommend for or against routine VTED prophylaxis for

More information

The Evaluation of the Accounting Education Provided in Vocational High Schools in Turkey from the Perspective of Students

The Evaluation of the Accounting Education Provided in Vocational High Schools in Turkey from the Perspective of Students International Journal of Business and Social Science Vol. 3 No. 22 [Special Issue November 2012] The Evaluation of the Accounting Education Provided in Vocational High Schools in Turkey from the Perspective

More information

LAMC Reversal Agent Guideline for Anticoagulants 2013. Time to resolution of hemostasis (hrs) Therapeutic Options

LAMC Reversal Agent Guideline for Anticoagulants 2013. Time to resolution of hemostasis (hrs) Therapeutic Options LAMC Reversal Agent Guideline for Anticoagulants 2013 Medication resolution of hemostasis (hrs) Intervention Administration Instructions Heparin 3-4 Protamine 1mg IV for every 100 units of heparin Slow

More information

Specific Standards of Accreditation for Residency Programs in General Surgery

Specific Standards of Accreditation for Residency Programs in General Surgery Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the

More information

New anticoagulants: Monitoring or not Monitoring? Not Monitoring

New anticoagulants: Monitoring or not Monitoring? Not Monitoring The 2 nd World Congress on CONTROVERSIES IN HEMATOLOGY (COHEM) Barcelona, Spain September 6 8, 2012 New anticoagulants: Monitoring or not Monitoring? Not Monitoring Anna Falanga, MD Immunohematology and

More information

Clinical Guideline N/A. November 2013

Clinical Guideline N/A. November 2013 State if the document is a Trust Policy/Procedure or a Clinical Guideline Clinical Guideline Document Title: Document Number 352 Version Number 1 Name and date and version number of previous document (if

More information

CLINICAL GUIDELINE FOR MANAGEMENTS OF PATIENTS TAKING ANTICOAGULANTS IN ENDOSCOPY 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR MANAGEMENTS OF PATIENTS TAKING ANTICOAGULANTS IN ENDOSCOPY 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR MANAGEMENTS OF PATIENTS TAKING ANTICOAGULANTS IN ENDOSCOPY 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to assist decision making of whether anticoagulants

More information

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs). MANAGEMENT OF BLEEDING IN PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To assist clinicians

More information

Investor News. Not intended for U.S. and UK media

Investor News. Not intended for U.S. and UK media Investor News Not intended for U.S. and UK media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer s Xarelto (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

LEBENSLAUF Dent. Dr. ÖZGE ÖZTÜRK

LEBENSLAUF Dent. Dr. ÖZGE ÖZTÜRK LEBENSLAUF Dent. Dr. ÖZGE ÖZTÜRK 1. EDUCATION AND TRAINING Year Position/Title School/University Field 1987-1994 Student T.E.D. Ankara College, Ankara, TURKEY High School (honour student) 1994-1999 Student

More information

Summa Health System. A Woman s Guide to Hysterectomy

Summa Health System. A Woman s Guide to Hysterectomy Summa Health System A Woman s Guide to Hysterectomy Hysterectomy A hysterectomy is a surgical procedure to remove a woman s uterus (womb). The uterus is the organ which shelters and nourishes a baby during

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

Review of Non-VKA Oral AntiCoagulants (NOACs) and their use in Great Britain

Review of Non-VKA Oral AntiCoagulants (NOACs) and their use in Great Britain Review of Non-VKA Oral AntiCoagulants (NOACs) and their use in Great Britain Dr Alexander (Ander) Cohen Guy s and St Thomas Hospitals, King s College London, UK Pavia Spring Meeting 13 June 2014 Overview

More information

CAPITAL INVESTMENT DECISIONS IN SMALL AND MEDIUM SIZED ENTERPRISES IN TURKEY. Gokhan Sungun* * Ph.D., CPA, CIA, CCSA, CRMA, Independent Researcher

CAPITAL INVESTMENT DECISIONS IN SMALL AND MEDIUM SIZED ENTERPRISES IN TURKEY. Gokhan Sungun* * Ph.D., CPA, CIA, CCSA, CRMA, Independent Researcher CAPITAL INVESTMENT DECISIONS IN SMALL AND MEDIUM SIZED ENTERPRISES IN TURKEY Gokhan Sungun* * Ph.D., CPA, CIA, CCSA, CRMA, Independent Researcher ABSTRACT: As accepted by economists, Small and Medium Sized

More information

TURKISH ACADEMY OF UROLOGY APPLIED LAPAROSCOPIC UROLOGY COURSE February 13-14, 2015 / İstanbul

TURKISH ACADEMY OF UROLOGY APPLIED LAPAROSCOPIC UROLOGY COURSE February 13-14, 2015 / İstanbul Invitation letter from Course President Dear Colleagues, On behalf of the Executive Committee of Turkish Urology and Endourology Associations and Acibadem University Laboratory Animal Application and Research

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

MANAGING BLEEDING IN THE

MANAGING BLEEDING IN THE MANAGING BLEEDING IN THE SETTING OF NEW ANTICOAGULANTS: HOW DO OLD METHODS MEASURE UP? Michelle Zeller MD Clinical Hematology Fellow November 5th, 2011 A FRIDAY NIGHT ON-CALL WITH DR. B. LUD Very keen

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Center for Endoscopic Research & Therapeutics

Center for Endoscopic Research & Therapeutics Center for Endoscopic Research & Therapeutics 5758 South Maryland Avenue (MC9028) Chicago, Illinois 60637 (773) 702-1459 www.uchospitals.edu Center for Endoscopic Research & Therapeutics To refer a patient

More information

The management of cerebral hemorrhagic complications during anticoagulant therapy

The management of cerebral hemorrhagic complications during anticoagulant therapy The management of cerebral hemorrhagic complications during anticoagulant therapy Maurizio Paciaroni Stroke Unit Division of Cardiovascular Medicine University of Perugia - Italy Perugia Stroke Registry

More information

Now We Got Bad Blood: New Anticoagulant Reversal

Now We Got Bad Blood: New Anticoagulant Reversal Now We Got Bad Blood: New Anticoagulant Reversal Kellie Rodriguez, PharmD, BCPS PGY2 Emergency Medicine Pharmacy Resident UF Health Jacksonville January 2016 Objectives 1. Review current treatment strategies

More information

Evaluation of Trauma Patients Admitted to Emergency Department According to Triage Categories

Evaluation of Trauma Patients Admitted to Emergency Department According to Triage Categories 60 THE JOURNAL OF ACADEMIC EMERGENCY MEDICINE Original Article Evaluation of Trauma Patients Admitted to Emergency Department According to Triage Categories Suna Eraybar Pozam 1, Fatma Özdemir 2, Pınar

More information

Jordan University of Science and Technology (JUST) http://www.just.edu.jo/

Jordan University of Science and Technology (JUST) http://www.just.edu.jo/ Jordan University of Science and Technology (JUST) http://www.just.edu.jo/ Dr. Mahmoud Al Refaei JUST Campus One of the biggest in region. It covers more than 100 hectares Located in Irbid city, in the

More information

Dr Gordon Royle Haematologist, Middlemore Hospital

Dr Gordon Royle Haematologist, Middlemore Hospital The New Oral Anticoagulants (NOACs) Dr Gordon Royle Haematologist, Middlemore Hospital Disclaimers Boehringer-Ingelheim Bayer Sanofi Douglas Pharmaceuticals Preventing disasters: lessons learned A cautionary

More information

ESD for colorectal lesions I am in favour. Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy

ESD for colorectal lesions I am in favour. Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy ESD for colorectal lesions I am in favour Alessandro Repici, MD Digestive Endoscopy Unit IRCCS Istituto Clinico Humanitas Milano, Italy Surgery for early colonic lesions 51 pts referred for lap colectomy

More information

CURRICULUM VITAE Emir Yüzbaşıoğlu, D.D.S, Ph.D.

CURRICULUM VITAE Emir Yüzbaşıoğlu, D.D.S, Ph.D. CURRICULUM VITAE Emir Yüzbaşıoğlu, D.D.S, Ph.D. Birth Place : Kırklareli, TURKEY Date of Birth : February 12th, 1978 Nationality : TURKEY Business Address : Istanbul Medipol University, School of Dentistry,

More information

GI Bleed. Steven Lichtenstein, D.O. Chief, Division of Gastroenterology Mercy Health System. Director, Endoscopy/GI Lab Mercy Fitzgerald Hospital

GI Bleed. Steven Lichtenstein, D.O. Chief, Division of Gastroenterology Mercy Health System. Director, Endoscopy/GI Lab Mercy Fitzgerald Hospital October 3, 2015 GI Bleed Steven Lichtenstein, D.O. Chief, Division of Gastroenterology Mercy Health System Director, Endoscopy/GI Lab Mercy Fitzgerald Hospital Clinical Associate Professor of Medicine

More information

ABOUT XARELTO CLINICAL STUDIES

ABOUT XARELTO CLINICAL STUDIES ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

More information

Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment.

Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment. 1 Low dose capecitabine is effective and relatively nontoxic in breast cancer treatment. John T. Carpenter, M.D. University of Alabama at Birmingham NP 2508 1720 Second Avenue South Birmingham, AL 35294-3300

More information

SMALL CELL LUNG CANCER

SMALL CELL LUNG CANCER Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New

More information

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation October 2013 This report has been prepared by a multiprofessional collaborative group, with support

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

TRI Product NewsFlash. December 2015

TRI Product NewsFlash. December 2015 TRI Product NewsFlash December 2015 Study Overview 2015 Dear Partners Year in, year out, we are screening all major scientific journals to ensure that our TRI Performance Concept still reflects the latest

More information

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.

More information

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE

FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE www.bpac.org.nz keyword: warfarinaspirin FOR THE PREVENTION OF ATRIAL FIBRILLATION RELATED STROKE Key Concepts In atrial fibrillation (AF) warfarin is more effective than aspirin for stroke prevention.

More information

CURRENT CHALLENGES OF THE GYNECOLOGY ASS STANTS IN TURKEY

CURRENT CHALLENGES OF THE GYNECOLOGY ASS STANTS IN TURKEY CLINICAL INVESTIGATION (Araflt rma) CURRENT CHALLENGES OF THE GYNECOLOGY ASS STANTS IN TURKEY Yusuf Taner KAFADAR 1, Funda GODE 2, Cansun DEMIR 3, Ali BALOGLU 4 1 Department of Obstetrics and Gynecology,

More information

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics GI Bleeding Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics Overview Because GI bleeding is internal, it is possible for a person to have GI bleeding without symptoms. Important to recognize

More information

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also

More information

Considering a Hysterectomy?

Considering a Hysterectomy? Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Adenomyosis,

More information

Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S.

Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S. Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint

More information

Friday April 8 th 2016

Friday April 8 th 2016 Preliminary Scientific Program - ICTHIC April 8-10, 2016 Friday April 8 th 2016 9,00-11,00 am Industry sponsored session 11,00-11,15 am Congress Opening: A Falanga, FR Rickles, B Brenner 11,15-1,30 pm

More information

Dr Gordon Royle Haematologist, Middlemore Hospital

Dr Gordon Royle Haematologist, Middlemore Hospital The New Oral Anticoagulants (NOACs) Dr Gordon Royle Haematologist, Middlemore Hospital Disclaimers Boehringer-Ingelheim Bayer Sanofi Douglas Pharmaceuticals Preventing disasters: lessons learned A cautionary

More information

School of Nursing and Midwifery. School of Nutritional Sciences and Dietetics

School of Nursing and Midwifery. School of Nutritional Sciences and Dietetics ABOUTTUMS Tehran University of Medical Sciences is the oldest and most well-known medical center in Iran. It is one of the country s top research universities which accepts applications from the most qualified

More information

How To Manage An Anticoagulant

How To Manage An Anticoagulant PERI-OPERATIVE MANAGEMENT OF PATIENTS WHO ARE RECEIVING A NEW ORAL ANTICOAGULANT (DABIGATRAN, RIVAROXABAN, APIXABAN) TARGET AUDIENCE: All Canadian health care professionals, including primary care physicians,

More information

Internet usage and parents views about internet addiction 1

Internet usage and parents views about internet addiction 1 Volume: 8 Issue: 1 Year: 2011 Internet usage and parents views about internet addiction 1 emseddin Gündüz 2 emsettin ahin 3 Abstract The purpose of this study; families to identify the measures they have

More information

Stroke Risk Scores. CHA 2 DS 2 -VASc. CHA 2 DS 2 -VASc Scoring Table 2

Stroke Risk Scores. CHA 2 DS 2 -VASc. CHA 2 DS 2 -VASc Scoring Table 2 Bleeding/Clotting Risk Evaluation Tools for Atrial Fibrillation Patients Before prescribing anticoagulants, providers should weigh the risk of thrombosis against the risk of bleeding. The tools below can

More information

Cost-Saving Approach to Patients on Long-Term Anticoagulation Who Need Endoscopy: A Decision Analysis

Cost-Saving Approach to Patients on Long-Term Anticoagulation Who Need Endoscopy: A Decision Analysis THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 98, No. 8, 2003 2003 by Am. Coll. of Gastroenterology ISSN 0002-9270/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0002-9270(03)00445-3 Cost-Saving Approach

More information

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h See EMR adult VTE prophylaxis CI order set Enoxaparin See service specific dosing Assess

More information